EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of complement in glomerulonephritis—are novel therapies ready for prime time?

Chee Kay Cheung iD, John P Dormer iD, Jonathan Barratt iD

Nephrology Dialysis Transplantation · 31.07.2023 · 38 (8) · 1789-1797

DOI: 10.1093/ndt/gfac296 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 28.10.2022. Verfasst von Chee Kay Cheung und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, University of Leicester, Leicester, UK. Hauptthemen laut MEDLINE: Glomerulonephritis, Glomerulonephritis, Membranous, Glomerulonephritis, IGA, Lupus Nephritis. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: GlaxoSmithKline, Travere Therapeutics, Novartis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The complement system plays a key pathogenic role in glomerular diseases with a diverse range of aetiologies, including C3 glomerulopathy, immunoglobulin A nephropathy, membranous nephropathy, ANCA-associated vasculitis and lupus nephritis. Several novel therapies targeting complement activity have recently been developed, which have now been approved or are in the late stages of clinical development. In this review, potential benefits and challenges of targeting the complement system in glomerular disease are discussed. We summarize current understanding of the role of complement, and the novel targeted therapies that are being developed for the treatment of glomerular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlomerulonephritisGlomerulonephritis, MembranousGlomerulonephritis, IGALupus NephritisHumansComplement System Proteins

Stichwörter der Autor:innen

IgA nephropathycomplementglomerulonephritislupus nephritisvasculitis

Substanzen

Complement System Proteins

Autor:innen und Institutionen

  • Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
  • John Walls Renal Unit, University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Department of Histopathology, University Hospitals of Leicester NHS Trust, Leicester, UK.

ORCID-Profile: Chee Kay Cheung, John P Dormer, Jonathan Barratt

Förderung

  • GlaxoSmithKline
  • Travere Therapeutics
  • Novartis

Zitieren

APA

Cheung, C. K., Dormer, J. P., & Barratt, J. (2023). The role of complement in glomerulonephritis—are novel therapies ready for prime time?. Nephrology Dialysis Transplantation, 38(8), 1789-1797. https://doi.org/10.1093/ndt/gfac296

Vancouver

Cheung CK, Dormer JP, Barratt J. The role of complement in glomerulonephritis—are novel therapies ready for prime time?. Nephrology Dialysis Transplantation. 2023;38(8):1789-1797. doi:10.1093/ndt/gfac296

BibTeX
@article{Cheung2023,
  author = {Cheung, Chee Kay and Dormer, John P and Barratt, Jonathan},
  title = {The role of complement in glomerulonephritis—are novel therapies ready for prime time?},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  volume = {38},
  number = {8},
  pages = {1789--1797},
  doi = {10.1093/ndt/gfac296}
}
Kostenlos starten →